Gunars Gaikis is a partner in Smart & Biggar's Toronto office. He has over 30 years of experience in IP law and is experienced in the procurement, litigation and enforcement of pharmaceutical and biotechnology patent rights and strategic advising.
Gunars has appeared as lead counsel in many precedent setting IP cases before the Ontario, Federal and Supreme courts, including the June 30, 2017 Supreme Court of Canada decision in AstraZeneca v Apotex, which struck down the “promise of the patent” utility doctrine.
Among his many accolades, Gunars has been recognized annually as a “life Science Star” in the Canada Chapter of LMG Life Sciences since 2013 and identified as a “World IP Review Leader” since 2016. He has been named as one of the “World’s Leading Patent Professionals” by IAM Patent 1000 since 2012, an “IP leader” by Chambers Global – The World’s Leading Lawyers for Business since 2006, and named MIP’s 2018 “Outstanding IP Practitioner of the Year” in Canada. In 2015 Gunars was selected as “Canadian Patent Litigation Attorney of the Year” by LMG Life Sciences, and has been recognized as one of the top thirty patent lawyers in the world in Euromoney's Expert Guides since 2014.
Gunars is a Licensed pharmacist; completed residency program in clinical pharmacy. Registered Patent and Trademark Agent. Called to the Ontario Bar in 1983.
Last updated 1st June 2018